Restricted research access
Before you enter

Research access confirmation

Amino's supplies compounds exclusively for qualified laboratory research. Please confirm both statements below.

By entering, you agree to follow all applicable laws and institutional requirements. Your choice is remembered for 30 days.
For laboratory research purposes onlyNot for human or veterinary useBatch documentation availableU.S. research supplyFor laboratory research purposes only
Aminos Peps
Home/Products/GLP-2 (TRZ)
FOR RESEARCH USE ONLYGLP-2 (TRZ) Amino's Peps research vial
Dual-pathway research compound

GLP-2 (TRZ)

GLP-2Research standard
Out of stock

A focused peptide reference material supplied exclusively for controlled in-vitro laboratory research.

Currently out of stock

This product cannot be purchased right now. Contact us if you would like an availability update.

Request an availability update →
✓ Tracked U.S. shipping◇ Shipment protection↗ Batch documentation
Verified test results

Batch documentation, clearly presented.

Review the independent documentation supplied for this product. Each link opens the original laboratory verification record so qualified researchers can assess the report directly.

AP
GLP-2 (TRZ)Research profile
RUOResearch use only
ProfileStatusDetail
Compound informationAvailableTechnical overview
Scientific referencesAvailablePrimary sources
Current availabilityOut of stockCatalog status
Batch certificatePendingNot yet supplied

A 39-amino-acid synthetic research peptide described as a dual GIP and GLP-1 receptor agonist.

Batch certificate pending

No batch-specific certificate has been supplied to Amino's Peps for this out-of-stock listing. A qualifying report can be linked here when inventory is released.

Contact support →
Compound information

Technical specifications

◈

What is GLP-2 (TRZ)?

A 39-amino-acid synthetic research peptide described as a dual GIP and GLP-1 receptor agonist.

Research name
Tirzepatide
Type
Dual GIP / GLP-1 agonist
CAS number
2023788-19-2
Amino acids
39
Intended use
In-vitro research
◆

Research material guidance

  • Keep the container protected from light and excess moisture
  • Avoid unnecessary temperature cycling
  • Follow your institution's validated handling protocol
  • Restrict access to qualified laboratory personnel
Sources & references

Peer-reviewed research

External references are provided for scientific context only and do not constitute medical advice or product-use instructions.

New England Journal of Medicine · 2022Tirzepatide Once Weekly for the Treatment of ObesityJastreboff et al. · PMID 35658024View source ↗The Lancet Diabetes & Endocrinology · 2022Tirzepatide monotherapy compared with dulaglutide — Phase 3Inagaki et al. · PMID 35914543View source ↗PubChemTirzepatide compound recordCID 156588324View source ↗
Explore the catalog
GLP-3 (RT)Triple-Action Metabolic Compound

GLP-3 (RT)

View product →GHK-CuOut of stockDermal Compound

GHK-Cu

View product →BPC-157Out of stockCellular Peptide

BPC-157

View product →KLOWOut of stockCellular Peptide Blend

KLOW

View product →